Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genomics | 42 | 2024 | 5820 | 1.880 |
Why?
|
DNA Copy Number Variations | 28 | 2023 | 2020 | 1.870 |
Why?
|
Brain Neoplasms | 41 | 2024 | 9031 | 1.780 |
Why?
|
Genome, Human | 33 | 2024 | 4425 | 1.660 |
Why?
|
Glioma | 25 | 2024 | 3455 | 1.620 |
Why?
|
Gene Dosage | 22 | 2020 | 1218 | 1.620 |
Why?
|
Aneuploidy | 6 | 2023 | 551 | 1.570 |
Why?
|
Neoplasms | 49 | 2024 | 22164 | 1.450 |
Why?
|
Meningioma | 16 | 2022 | 1218 | 1.320 |
Why?
|
Glioblastoma | 28 | 2024 | 3482 | 1.290 |
Why?
|
Meningeal Neoplasms | 16 | 2022 | 1248 | 1.140 |
Why?
|
Genomic Structural Variation | 4 | 2020 | 68 | 1.040 |
Why?
|
Loss of Heterozygosity | 7 | 2020 | 662 | 0.950 |
Why?
|
Mutation | 66 | 2024 | 30045 | 0.920 |
Why?
|
Chromosome Aberrations | 12 | 2018 | 1771 | 0.900 |
Why?
|
Software | 7 | 2022 | 4434 | 0.890 |
Why?
|
Gene Expression Regulation, Neoplastic | 39 | 2021 | 8545 | 0.890 |
Why?
|
Oncogenes | 15 | 2023 | 1222 | 0.840 |
Why?
|
Azepines | 4 | 2019 | 329 | 0.820 |
Why?
|
Gene Amplification | 19 | 2018 | 1088 | 0.810 |
Why?
|
Cell Transformation, Neoplastic | 11 | 2023 | 2824 | 0.780 |
Why?
|
Medulloblastoma | 5 | 2019 | 678 | 0.770 |
Why?
|
Genes, Essential | 3 | 2020 | 185 | 0.750 |
Why?
|
Cell Line, Tumor | 65 | 2024 | 16979 | 0.720 |
Why?
|
Genetics, Population | 2 | 2021 | 939 | 0.660 |
Why?
|
Astrocytoma | 3 | 2019 | 775 | 0.660 |
Why?
|
High-Throughput Nucleotide Sequencing | 17 | 2022 | 3639 | 0.650 |
Why?
|
Triazoles | 4 | 2019 | 903 | 0.650 |
Why?
|
INDEL Mutation | 3 | 2020 | 266 | 0.630 |
Why?
|
Evolution, Molecular | 6 | 2020 | 1887 | 0.630 |
Why?
|
Neural Stem Cells | 3 | 2020 | 888 | 0.600 |
Why?
|
Genes, Tumor Suppressor | 12 | 2023 | 1062 | 0.590 |
Why?
|
Sequence Deletion | 3 | 2018 | 1494 | 0.570 |
Why?
|
Cell Cycle | 6 | 2022 | 2932 | 0.560 |
Why?
|
Cerebellar Neoplasms | 3 | 2019 | 586 | 0.550 |
Why?
|
Oligonucleotide Array Sequence Analysis | 14 | 2015 | 3779 | 0.550 |
Why?
|
Gene Rearrangement | 11 | 2020 | 1125 | 0.520 |
Why?
|
Proto-Oncogenes | 1 | 2016 | 321 | 0.490 |
Why?
|
Publications | 1 | 2017 | 194 | 0.490 |
Why?
|
Neurogenesis | 2 | 2019 | 862 | 0.480 |
Why?
|
Neoplasm Proteins | 7 | 2020 | 3612 | 0.460 |
Why?
|
Phosphatidylinositol 3-Kinases | 12 | 2018 | 2863 | 0.460 |
Why?
|
Gene Expression Profiling | 23 | 2019 | 9418 | 0.460 |
Why?
|
DNA Mutational Analysis | 15 | 2020 | 4110 | 0.460 |
Why?
|
Proto-Oncogene Proteins c-akt | 8 | 2018 | 2455 | 0.460 |
Why?
|
DNA Methylation | 9 | 2021 | 4391 | 0.450 |
Why?
|
Stomach Neoplasms | 4 | 2020 | 1459 | 0.440 |
Why?
|
Cell Lineage | 8 | 2023 | 2555 | 0.440 |
Why?
|
Sequence Analysis, DNA | 10 | 2020 | 4741 | 0.430 |
Why?
|
Translocation, Genetic | 3 | 2016 | 1393 | 0.430 |
Why?
|
Humans | 212 | 2024 | 761423 | 0.430 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2019 | 2054 | 0.430 |
Why?
|
Carcinoma, Renal Cell | 6 | 2018 | 3163 | 0.420 |
Why?
|
Tumor Suppressor Protein p53 | 12 | 2022 | 2916 | 0.420 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 651 | 0.410 |
Why?
|
Endometrial Neoplasms | 7 | 2018 | 1365 | 0.410 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 382 | 0.400 |
Why?
|
MicroRNAs | 7 | 2021 | 3812 | 0.390 |
Why?
|
Kidney Neoplasms | 8 | 2021 | 4248 | 0.390 |
Why?
|
Polymorphism, Single Nucleotide | 27 | 2021 | 15941 | 0.380 |
Why?
|
RNA-Binding Proteins | 5 | 2021 | 1897 | 0.380 |
Why?
|
Phosphoproteins | 3 | 2020 | 2448 | 0.380 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2021 | 5305 | 0.370 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1363 | 0.370 |
Why?
|
Germ-Line Mutation | 4 | 2024 | 1858 | 0.350 |
Why?
|
Publishing | 1 | 2017 | 833 | 0.350 |
Why?
|
Carcinoma, Medullary | 2 | 2021 | 115 | 0.340 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2021 | 1606 | 0.330 |
Why?
|
Chromosomes, Human, Pair 8 | 3 | 2023 | 452 | 0.330 |
Why?
|
Adaptor Proteins, Signal Transducing | 7 | 2020 | 2898 | 0.320 |
Why?
|
Proto-Oncogene Proteins c-myc | 5 | 2019 | 988 | 0.320 |
Why?
|
Computational Biology | 6 | 2021 | 3517 | 0.310 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2014 | 1250 | 0.310 |
Why?
|
bcl-X Protein | 4 | 2016 | 410 | 0.310 |
Why?
|
PTEN Phosphohydrolase | 9 | 2018 | 1115 | 0.310 |
Why?
|
Nuclear Proteins | 12 | 2024 | 5794 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 10 | 2021 | 17912 | 0.300 |
Why?
|
Comparative Genomic Hybridization | 9 | 2017 | 473 | 0.300 |
Why?
|
von Hippel-Lindau Disease | 1 | 2009 | 151 | 0.300 |
Why?
|
Genomic Instability | 4 | 2019 | 709 | 0.290 |
Why?
|
Adenocarcinoma | 7 | 2020 | 6339 | 0.290 |
Why?
|
Histones | 7 | 2024 | 2580 | 0.290 |
Why?
|
DNA, Neoplasm | 11 | 2021 | 1745 | 0.290 |
Why?
|
Transcription Factors | 15 | 2024 | 12125 | 0.290 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2022 | 9277 | 0.280 |
Why?
|
Alleles | 8 | 2021 | 6922 | 0.270 |
Why?
|
Oligodendroglia | 3 | 2020 | 538 | 0.270 |
Why?
|
Cell Proliferation | 19 | 2021 | 10441 | 0.270 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2020 | 305 | 0.260 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 3 | 2020 | 368 | 0.260 |
Why?
|
Hedgehog Proteins | 4 | 2014 | 768 | 0.260 |
Why?
|
Tumor Suppressor Proteins | 6 | 2018 | 2803 | 0.260 |
Why?
|
Genetic Heterogeneity | 5 | 2021 | 732 | 0.260 |
Why?
|
Proteins | 3 | 2019 | 6032 | 0.250 |
Why?
|
Genes, Neoplasm | 5 | 2018 | 370 | 0.250 |
Why?
|
Epigenesis, Genetic | 9 | 2020 | 3798 | 0.250 |
Why?
|
Signal Transduction | 32 | 2020 | 23441 | 0.250 |
Why?
|
Genome | 3 | 2021 | 1740 | 0.250 |
Why?
|
Models, Genetic | 6 | 2021 | 3446 | 0.240 |
Why?
|
Databases, Genetic | 7 | 2021 | 1742 | 0.240 |
Why?
|
Angiogenesis Inhibitors | 4 | 2019 | 2047 | 0.240 |
Why?
|
Transcription, Genetic | 10 | 2021 | 7595 | 0.240 |
Why?
|
Chromosomes, Human, Pair 14 | 3 | 2016 | 287 | 0.240 |
Why?
|
MAP Kinase Signaling System | 3 | 2019 | 1486 | 0.230 |
Why?
|
Genes, p53 | 4 | 2015 | 712 | 0.230 |
Why?
|
Mice | 41 | 2023 | 81509 | 0.230 |
Why?
|
Mice, Nude | 13 | 2019 | 3614 | 0.230 |
Why?
|
DNA-Binding Proteins | 10 | 2020 | 9606 | 0.230 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 6 | 2018 | 1743 | 0.230 |
Why?
|
In Situ Hybridization, Fluorescence | 11 | 2019 | 2510 | 0.230 |
Why?
|
Pituitary Neoplasms | 3 | 2017 | 1324 | 0.220 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2019 | 561 | 0.220 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2019 | 1135 | 0.220 |
Why?
|
Chromatin | 4 | 2020 | 2960 | 0.210 |
Why?
|
Jaundice, Neonatal | 1 | 2003 | 71 | 0.210 |
Why?
|
Gene Fusion | 4 | 2016 | 356 | 0.210 |
Why?
|
Chromosomes, Human, Pair 5 | 2 | 2014 | 386 | 0.210 |
Why?
|
Thyrotoxicosis | 1 | 2003 | 85 | 0.210 |
Why?
|
Neuroblastoma | 2 | 2022 | 1250 | 0.200 |
Why?
|
Centromere | 1 | 2023 | 213 | 0.200 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2022 | 42 | 0.200 |
Why?
|
Vaccinia | 1 | 2022 | 71 | 0.200 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 5 | 2018 | 898 | 0.200 |
Why?
|
Esophageal Neoplasms | 5 | 2020 | 1649 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 7 | 2022 | 4510 | 0.200 |
Why?
|
Haplotypes | 4 | 2021 | 2775 | 0.200 |
Why?
|
Cell Cycle Proteins | 8 | 2024 | 3447 | 0.190 |
Why?
|
Animals | 49 | 2023 | 168441 | 0.190 |
Why?
|
Prostatic Neoplasms | 10 | 2010 | 11118 | 0.190 |
Why?
|
Proteasome Endopeptidase Complex | 4 | 2019 | 1320 | 0.190 |
Why?
|
Graves Disease | 1 | 2003 | 238 | 0.190 |
Why?
|
ras GTPase-Activating Proteins | 2 | 2013 | 94 | 0.190 |
Why?
|
Dacarbazine | 2 | 2015 | 559 | 0.190 |
Why?
|
Molecular Targeted Therapy | 6 | 2019 | 2811 | 0.190 |
Why?
|
Trans-Activators | 5 | 2013 | 2856 | 0.190 |
Why?
|
Neoplasm Metastasis | 9 | 2018 | 4912 | 0.190 |
Why?
|
Apoptosis | 9 | 2020 | 9488 | 0.180 |
Why?
|
Maternal-Fetal Exchange | 1 | 2003 | 463 | 0.180 |
Why?
|
Cloning, Organism | 1 | 2020 | 50 | 0.180 |
Why?
|
Tachykinins | 1 | 2021 | 77 | 0.180 |
Why?
|
S Phase | 2 | 2019 | 421 | 0.180 |
Why?
|
Peptide Nucleic Acids | 1 | 2020 | 26 | 0.180 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2020 | 3602 | 0.170 |
Why?
|
Neoplasm Transplantation | 8 | 2019 | 2016 | 0.170 |
Why?
|
Neoplasm Invasiveness | 8 | 2018 | 3589 | 0.170 |
Why?
|
DNA Primase | 1 | 2020 | 110 | 0.170 |
Why?
|
Chromosomes, Human, Pair 1 | 4 | 2019 | 638 | 0.170 |
Why?
|
Genetic Variation | 6 | 2024 | 6581 | 0.160 |
Why?
|
Cyclin D2 | 1 | 2019 | 98 | 0.160 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 33 | 0.160 |
Why?
|
Telomere | 2 | 2023 | 941 | 0.160 |
Why?
|
Cluster Analysis | 6 | 2016 | 2706 | 0.160 |
Why?
|
Gene Deletion | 9 | 2020 | 2667 | 0.160 |
Why?
|
Melanoma | 5 | 2022 | 5709 | 0.160 |
Why?
|
Tumor Cells, Cultured | 5 | 2019 | 6132 | 0.160 |
Why?
|
Retroelements | 1 | 2020 | 163 | 0.160 |
Why?
|
Telomerase | 4 | 2020 | 745 | 0.160 |
Why?
|
Algorithms | 10 | 2022 | 14026 | 0.160 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 68 | 0.160 |
Why?
|
Phenotype | 12 | 2021 | 16606 | 0.160 |
Why?
|
Genes, myc | 3 | 2018 | 390 | 0.150 |
Why?
|
Antineoplastic Agents | 9 | 2019 | 13637 | 0.150 |
Why?
|
Chromosome Deletion | 7 | 2018 | 1387 | 0.150 |
Why?
|
Receptors, Androgen | 2 | 2018 | 1079 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2019 | 126 | 0.150 |
Why?
|
Interleukin-9 | 1 | 2018 | 61 | 0.150 |
Why?
|
Quinazolines | 4 | 2015 | 1371 | 0.150 |
Why?
|
Morpholines | 2 | 2019 | 581 | 0.150 |
Why?
|
Chromosomes, Human, Pair 3 | 3 | 2018 | 322 | 0.150 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2020 | 330 | 0.150 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2013 | 682 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 7 | 2023 | 5665 | 0.150 |
Why?
|
Pyridazines | 1 | 2019 | 202 | 0.150 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2016 | 1893 | 0.150 |
Why?
|
Salvage Therapy | 2 | 2014 | 1264 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 350 | 0.140 |
Why?
|
Female | 66 | 2022 | 392581 | 0.140 |
Why?
|
Oligonucleotides, Antisense | 1 | 2020 | 461 | 0.140 |
Why?
|
Male | 61 | 2022 | 360736 | 0.140 |
Why?
|
RNA, Neoplasm | 3 | 2016 | 750 | 0.140 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2018 | 223 | 0.140 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2018 | 455 | 0.140 |
Why?
|
Aminopyridines | 2 | 2019 | 573 | 0.140 |
Why?
|
Lung Neoplasms | 8 | 2021 | 13337 | 0.140 |
Why?
|
Cell Survival | 8 | 2020 | 5790 | 0.140 |
Why?
|
RNA Interference | 7 | 2019 | 2831 | 0.140 |
Why?
|
Indazoles | 1 | 2018 | 304 | 0.140 |
Why?
|
Urothelium | 1 | 2019 | 269 | 0.140 |
Why?
|
ras Proteins | 4 | 2015 | 1053 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 3 | 2020 | 789 | 0.140 |
Why?
|
DNA Repair | 4 | 2024 | 2045 | 0.140 |
Why?
|
Neoplasms, Second Primary | 2 | 2022 | 1051 | 0.140 |
Why?
|
ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 5 | 2020 | 698 | 0.130 |
Why?
|
RNA, Small Interfering | 7 | 2014 | 3428 | 0.130 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 158 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1090 | 0.130 |
Why?
|
Genes, X-Linked | 1 | 2016 | 128 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
Histone Demethylases | 1 | 2019 | 320 | 0.130 |
Why?
|
Chromosomes, Human | 2 | 2016 | 442 | 0.130 |
Why?
|
Cyclin E | 2 | 2014 | 156 | 0.130 |
Why?
|
Ploidies | 2 | 2013 | 285 | 0.130 |
Why?
|
Ear Neoplasms | 1 | 2016 | 118 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2019 | 1246 | 0.130 |
Why?
|
Virus Integration | 1 | 2018 | 304 | 0.130 |
Why?
|
Interneurons | 1 | 2020 | 593 | 0.130 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2015 | 373 | 0.130 |
Why?
|
Disease Progression | 14 | 2019 | 13502 | 0.130 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 193 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2016 | 375 | 0.130 |
Why?
|
Receptor, trkB | 1 | 2016 | 124 | 0.130 |
Why?
|
Drug Carriers | 1 | 2020 | 706 | 0.130 |
Why?
|
Sequence Alignment | 2 | 2017 | 2179 | 0.130 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2018 | 1405 | 0.130 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 97 | 0.130 |
Why?
|
Disease-Free Survival | 8 | 2018 | 6814 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 641 | 0.120 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2016 | 269 | 0.120 |
Why?
|
Oncogene Proteins | 3 | 2014 | 718 | 0.120 |
Why?
|
Documentation | 1 | 2021 | 897 | 0.120 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 210 | 0.120 |
Why?
|
Prognosis | 12 | 2022 | 29620 | 0.120 |
Why?
|
Ovarian Neoplasms | 6 | 2014 | 4876 | 0.120 |
Why?
|
Adenoma, Oxyphilic | 1 | 2016 | 148 | 0.120 |
Why?
|
Oligodendroglioma | 2 | 2014 | 279 | 0.120 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 321 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 287 | 0.120 |
Why?
|
Craniopharyngioma | 1 | 2017 | 277 | 0.120 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 227 | 0.120 |
Why?
|
Cytosine | 1 | 2015 | 211 | 0.120 |
Why?
|
Antigens, Bacterial | 1 | 2020 | 1155 | 0.120 |
Why?
|
Vestibule, Labyrinth | 1 | 2016 | 234 | 0.120 |
Why?
|
Bacterial Toxins | 1 | 2020 | 931 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2012 | 1405 | 0.120 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 247 | 0.120 |
Why?
|
Mice, Inbred NOD | 5 | 2020 | 1827 | 0.120 |
Why?
|
Immunohistochemistry | 8 | 2016 | 11073 | 0.120 |
Why?
|
Mutagenesis | 2 | 2020 | 1232 | 0.120 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2015 | 187 | 0.110 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2116 | 0.110 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2020 | 617 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2015 | 570 | 0.110 |
Why?
|
Genome-Wide Association Study | 6 | 2020 | 12688 | 0.110 |
Why?
|
Chromosome Mapping | 4 | 2016 | 4638 | 0.110 |
Why?
|
Astrocytes | 3 | 2020 | 1345 | 0.110 |
Why?
|
Chromosomes | 1 | 2017 | 577 | 0.110 |
Why?
|
GRB10 Adaptor Protein | 1 | 2013 | 23 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2022 | 2871 | 0.110 |
Why?
|
Semantics | 1 | 2017 | 601 | 0.110 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2013 | 72 | 0.110 |
Why?
|
Imidazoles | 1 | 2019 | 1180 | 0.110 |
Why?
|
Precancerous Conditions | 1 | 2020 | 980 | 0.110 |
Why?
|
Pentose Phosphate Pathway | 1 | 2013 | 126 | 0.110 |
Why?
|
Piperidines | 3 | 2018 | 1656 | 0.100 |
Why?
|
Oncogenic Viruses | 1 | 2012 | 37 | 0.100 |
Why?
|
Somatostatin | 1 | 2014 | 447 | 0.100 |
Why?
|
Child | 17 | 2024 | 80162 | 0.100 |
Why?
|
Ependymoma | 1 | 2016 | 320 | 0.100 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2014 | 412 | 0.100 |
Why?
|
Drug Synergism | 1 | 2016 | 1755 | 0.100 |
Why?
|
Chromosome Breakage | 1 | 2012 | 159 | 0.100 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2010 | 256 | 0.100 |
Why?
|
Cyclin D1 | 1 | 2014 | 451 | 0.100 |
Why?
|
Citric Acid Cycle | 1 | 2013 | 231 | 0.100 |
Why?
|
Adult | 33 | 2024 | 221148 | 0.100 |
Why?
|
Hydroxamic Acids | 1 | 2015 | 481 | 0.100 |
Why?
|
Genetic Techniques | 2 | 2012 | 427 | 0.100 |
Why?
|
Breast Neoplasms | 9 | 2018 | 21012 | 0.100 |
Why?
|
Interferon-gamma | 1 | 2020 | 3159 | 0.100 |
Why?
|
Survival Analysis | 5 | 2018 | 10089 | 0.100 |
Why?
|
Genetic Association Studies | 3 | 2021 | 2734 | 0.100 |
Why?
|
Neurofibromin 1 | 2 | 2012 | 190 | 0.100 |
Why?
|
Neurofibromin 2 | 1 | 2013 | 270 | 0.100 |
Why?
|
Phosphoglycerate Dehydrogenase | 1 | 2011 | 37 | 0.100 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 491 | 0.100 |
Why?
|
Probability | 2 | 2007 | 2478 | 0.100 |
Why?
|
Genetic Testing | 2 | 2014 | 3538 | 0.100 |
Why?
|
Microsatellite Repeats | 2 | 2020 | 785 | 0.100 |
Why?
|
Protein Methyltransferases | 1 | 2011 | 53 | 0.090 |
Why?
|
Middle Aged | 34 | 2020 | 220826 | 0.090 |
Why?
|
Aged | 30 | 2020 | 169235 | 0.090 |
Why?
|
Neurilemmoma | 1 | 2016 | 526 | 0.090 |
Why?
|
Clone Cells | 3 | 2020 | 1659 | 0.090 |
Why?
|
DNA Breaks | 2 | 2021 | 47 | 0.090 |
Why?
|
Trisomy | 1 | 2012 | 260 | 0.090 |
Why?
|
Cerebrum | 1 | 2012 | 132 | 0.090 |
Why?
|
Polymerase Chain Reaction | 5 | 2007 | 6086 | 0.090 |
Why?
|
Biotechnology | 2 | 2012 | 282 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2723 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2015 | 829 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2016 | 851 | 0.090 |
Why?
|
Multigene Family | 2 | 2013 | 1077 | 0.090 |
Why?
|
Dogs | 1 | 2015 | 3839 | 0.090 |
Why?
|
Microglia | 1 | 2019 | 1361 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2014 | 487 | 0.090 |
Why?
|
Stathmin | 1 | 2010 | 70 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 2 | 2015 | 1974 | 0.090 |
Why?
|
Genes, ras | 2 | 2010 | 654 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 785 | 0.090 |
Why?
|
Virology | 1 | 2010 | 75 | 0.090 |
Why?
|
Serine Endopeptidases | 3 | 2016 | 1021 | 0.090 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2010 | 55 | 0.090 |
Why?
|
Promoter Regions, Genetic | 6 | 2020 | 5789 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11740 | 0.090 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 469 | 0.090 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2019 | 938 | 0.090 |
Why?
|
Carrier Proteins | 4 | 2021 | 4936 | 0.090 |
Why?
|
Haploinsufficiency | 1 | 2012 | 337 | 0.090 |
Why?
|
Malformations of Cortical Development | 1 | 2012 | 176 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2016 | 716 | 0.090 |
Why?
|
Disease Models, Animal | 8 | 2022 | 18247 | 0.090 |
Why?
|
Receptors, HIV | 1 | 2010 | 159 | 0.080 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 598 | 0.080 |
Why?
|
DNA Damage | 2 | 2022 | 2446 | 0.080 |
Why?
|
Base Sequence | 4 | 2014 | 12450 | 0.080 |
Why?
|
Sequence Analysis, RNA | 4 | 2019 | 2020 | 0.080 |
Why?
|
Germ Cells | 2 | 2024 | 634 | 0.080 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2014 | 851 | 0.080 |
Why?
|
DNA Helicases | 3 | 2024 | 851 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2003 | 2947 | 0.080 |
Why?
|
Models, Biological | 4 | 2020 | 9469 | 0.080 |
Why?
|
Sulfonamides | 1 | 2018 | 1975 | 0.080 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2009 | 192 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1784 | 0.080 |
Why?
|
Mice, SCID | 4 | 2016 | 2626 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2018 | 4021 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 633 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 940 | 0.080 |
Why?
|
Protein Binding | 6 | 2021 | 9352 | 0.080 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2009 | 375 | 0.080 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2011 | 507 | 0.080 |
Why?
|
Adenosine Triphosphatases | 1 | 2013 | 834 | 0.080 |
Why?
|
NF-kappa B | 3 | 2014 | 2488 | 0.080 |
Why?
|
Gene Frequency | 2 | 2020 | 3647 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2013 | 5302 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2009 | 314 | 0.070 |
Why?
|
Gene Regulatory Networks | 2 | 2013 | 1743 | 0.070 |
Why?
|
Child, Preschool | 8 | 2022 | 42254 | 0.070 |
Why?
|
SOXB1 Transcription Factors | 1 | 2009 | 286 | 0.070 |
Why?
|
Recombination, Genetic | 1 | 2012 | 1525 | 0.070 |
Why?
|
Gene Expression | 3 | 2022 | 7584 | 0.070 |
Why?
|
Cranial Irradiation | 1 | 2010 | 390 | 0.070 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1155 | 0.070 |
Why?
|
Repressor Proteins | 2 | 2016 | 2985 | 0.070 |
Why?
|
DNA Repair Enzymes | 2 | 2024 | 346 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2826 | 0.070 |
Why?
|
beta Catenin | 1 | 2012 | 1040 | 0.070 |
Why?
|
Liposarcoma | 1 | 2010 | 289 | 0.070 |
Why?
|
Karnofsky Performance Status | 2 | 2019 | 166 | 0.070 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 1035 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 618 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 916 | 0.070 |
Why?
|
Oxygen | 1 | 2019 | 4228 | 0.070 |
Why?
|
Cholangiocarcinoma | 1 | 2013 | 552 | 0.070 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 369 | 0.070 |
Why?
|
Glycolysis | 1 | 2011 | 836 | 0.070 |
Why?
|
Mutagenesis, Insertional | 2 | 2020 | 656 | 0.070 |
Why?
|
Aged, 80 and over | 14 | 2019 | 58956 | 0.070 |
Why?
|
Seizures | 2 | 2024 | 2957 | 0.070 |
Why?
|
Survivors | 2 | 2014 | 2371 | 0.070 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3874 | 0.070 |
Why?
|
Indoles | 1 | 2015 | 1832 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2160 | 0.070 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2019 | 350 | 0.070 |
Why?
|
Virus Internalization | 1 | 2010 | 496 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2014 | 1520 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2015 | 6479 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2223 | 0.070 |
Why?
|
Cohort Studies | 10 | 2022 | 41446 | 0.070 |
Why?
|
Immunotherapy, Adoptive | 3 | 2022 | 1469 | 0.070 |
Why?
|
Colonic Neoplasms | 3 | 2012 | 2538 | 0.070 |
Why?
|
Survival Rate | 6 | 2015 | 12720 | 0.070 |
Why?
|
Saposins | 1 | 2005 | 26 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2008 | 1085 | 0.060 |
Why?
|
src-Family Kinases | 3 | 2015 | 535 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 727 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 8000 | 0.060 |
Why?
|
DNA Modification Methylases | 2 | 2018 | 210 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3702 | 0.060 |
Why?
|
Transplantation, Heterologous | 4 | 2017 | 2386 | 0.060 |
Why?
|
Young Adult | 12 | 2022 | 59207 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2022 | 4278 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 3 | 2018 | 655 | 0.060 |
Why?
|
Neoplasms, Experimental | 3 | 2020 | 1230 | 0.060 |
Why?
|
Chromosomes, Human, Y | 1 | 2006 | 161 | 0.060 |
Why?
|
Viral Proteins | 1 | 2012 | 1803 | 0.060 |
Why?
|
Enzyme Activation | 3 | 2019 | 3597 | 0.060 |
Why?
|
Genotype | 7 | 2021 | 13009 | 0.060 |
Why?
|
Tissue Engineering | 1 | 2015 | 1867 | 0.060 |
Why?
|
Bacillus Phages | 1 | 2004 | 12 | 0.060 |
Why?
|
Retrospective Studies | 12 | 2023 | 80582 | 0.060 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2012 | 954 | 0.060 |
Why?
|
Gene Duplication | 2 | 2018 | 314 | 0.060 |
Why?
|
Neurofibromatosis 1 | 1 | 2009 | 560 | 0.060 |
Why?
|
Adolescent | 10 | 2022 | 88313 | 0.060 |
Why?
|
DNA | 2 | 2021 | 7219 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1458 | 0.060 |
Why?
|
Infant | 5 | 2022 | 36205 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2014 | 17644 | 0.050 |
Why?
|
False Negative Reactions | 1 | 2024 | 573 | 0.050 |
Why?
|
Cell Line | 5 | 2024 | 15605 | 0.050 |
Why?
|
RNA, Messenger | 4 | 2022 | 12796 | 0.050 |
Why?
|
Carcinoma, Small Cell | 1 | 2005 | 420 | 0.050 |
Why?
|
Combined Modality Therapy | 4 | 2018 | 8529 | 0.050 |
Why?
|
raf Kinases | 2 | 2016 | 118 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2023 | 2328 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2020 | 14409 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2008 | 2423 | 0.050 |
Why?
|
Protein Structure, Tertiary | 4 | 2013 | 3792 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14599 | 0.050 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 435 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2011 | 2571 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2014 | 502 | 0.050 |
Why?
|
Proteomics | 1 | 2015 | 3845 | 0.050 |
Why?
|
Androgens | 2 | 2009 | 1286 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2691 | 0.050 |
Why?
|
Diploidy | 1 | 2021 | 132 | 0.050 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2004 | 489 | 0.050 |
Why?
|
Vaccinia virus | 1 | 2022 | 331 | 0.050 |
Why?
|
Radiosurgery | 1 | 2010 | 1342 | 0.050 |
Why?
|
DEAD-box RNA Helicases | 2 | 2014 | 384 | 0.040 |
Why?
|
Gene Silencing | 2 | 2020 | 1509 | 0.040 |
Why?
|
Genes, Lethal | 1 | 2021 | 225 | 0.040 |
Why?
|
Methylnitrosourea | 1 | 2020 | 30 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2014 | 2578 | 0.040 |
Why?
|
Chromosome Inversion | 1 | 2020 | 120 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2015 | 26212 | 0.040 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2020 | 97 | 0.040 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 2 | 2012 | 359 | 0.040 |
Why?
|
Brain Stem Neoplasms | 1 | 2022 | 190 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2011 | 2656 | 0.040 |
Why?
|
3T3 Cells | 2 | 2013 | 1085 | 0.040 |
Why?
|
Open Reading Frames | 2 | 2014 | 815 | 0.040 |
Why?
|
Chromosome Segregation | 1 | 2021 | 235 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2010 | 14664 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 2020 | 145 | 0.040 |
Why?
|
NIH 3T3 Cells | 2 | 2014 | 671 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 368 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 2013 | 4320 | 0.040 |
Why?
|
Kidney | 2 | 2019 | 7049 | 0.040 |
Why?
|
Glucose | 1 | 2011 | 4347 | 0.040 |
Why?
|
RNA Helicases | 1 | 2020 | 144 | 0.040 |
Why?
|
Pyridines | 3 | 2018 | 2875 | 0.040 |
Why?
|
Nervous System | 1 | 2022 | 545 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2022 | 328 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2018 | 64651 | 0.040 |
Why?
|
Mammary Glands, Human | 2 | 2013 | 203 | 0.040 |
Why?
|
Sarcoma | 1 | 2010 | 1801 | 0.040 |
Why?
|
Receptor, TIE-2 | 1 | 2019 | 176 | 0.040 |
Why?
|
Random Allocation | 1 | 2023 | 2394 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2020 | 340 | 0.040 |
Why?
|
Phylogeny | 2 | 2016 | 2811 | 0.040 |
Why?
|
Prosencephalon | 1 | 2020 | 305 | 0.040 |
Why?
|
Biphenyl Compounds | 2 | 2014 | 1007 | 0.040 |
Why?
|
Ki-67 Antigen | 2 | 2012 | 629 | 0.040 |
Why?
|
Tissue Array Analysis | 2 | 2010 | 550 | 0.040 |
Why?
|
Brain Mapping | 1 | 2014 | 6626 | 0.040 |
Why?
|
Neoplasm Staging | 4 | 2015 | 11106 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2018 | 2057 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2019 | 193 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 332 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2020 | 18964 | 0.040 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2019 | 171 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
Blotting, Western | 3 | 2011 | 5036 | 0.040 |
Why?
|
Streptococcus pyogenes | 1 | 2020 | 292 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2017 | 36423 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2008 | 2557 | 0.040 |
Why?
|
Receptors, Cell Surface | 3 | 2014 | 2821 | 0.040 |
Why?
|
Cell Shape | 1 | 2018 | 371 | 0.040 |
Why?
|
Zebrafish | 3 | 2014 | 3007 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 428 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2020 | 560 | 0.030 |
Why?
|
Binding Sites | 2 | 2021 | 6055 | 0.030 |
Why?
|
Pyrimidines | 3 | 2018 | 3027 | 0.030 |
Why?
|
Chromogranins | 1 | 2017 | 161 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 546 | 0.030 |
Why?
|
Models, Molecular | 3 | 2015 | 5439 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2019 | 656 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 705 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2021 | 612 | 0.030 |
Why?
|
Methylation | 1 | 2019 | 1083 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12456 | 0.030 |
Why?
|
Cell Division | 3 | 2009 | 4466 | 0.030 |
Why?
|
Lysine | 1 | 2020 | 992 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 558 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1316 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4575 | 0.030 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2015 | 38 | 0.030 |
Why?
|
Barrett Esophagus | 1 | 2020 | 492 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2016 | 223 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2015 | 39117 | 0.030 |
Why?
|
In Situ Hybridization | 2 | 2013 | 1900 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2018 | 385 | 0.030 |
Why?
|
Anticoagulants | 1 | 2011 | 4813 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2016 | 205 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.030 |
Why?
|
Phosphorylation | 3 | 2015 | 8320 | 0.030 |
Why?
|
Anilides | 1 | 2018 | 411 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10718 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2020 | 805 | 0.030 |
Why?
|
Cell Movement | 3 | 2014 | 5203 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2015 | 148 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 352 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2016 | 255 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2018 | 20093 | 0.030 |
Why?
|
Neoplastic Stem Cells | 2 | 2017 | 1347 | 0.030 |
Why?
|
Telomere-Binding Proteins | 1 | 2015 | 119 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 306 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2020 | 1675 | 0.030 |
Why?
|
Lomustine | 1 | 2014 | 60 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15262 | 0.030 |
Why?
|
Carmustine | 1 | 2014 | 138 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2017 | 590 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 839 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3522 | 0.030 |
Why?
|
Receptors, Somatostatin | 1 | 2014 | 136 | 0.030 |
Why?
|
F-Box Proteins | 1 | 2015 | 201 | 0.030 |
Why?
|
Homozygote | 2 | 2012 | 1796 | 0.030 |
Why?
|
Teratoma | 1 | 2016 | 404 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9535 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 740 | 0.030 |
Why?
|
Transcriptional Activation | 2 | 2010 | 1756 | 0.030 |
Why?
|
Mitochondria | 2 | 2016 | 3623 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-yes | 1 | 2012 | 15 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2013 | 203 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2416 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2017 | 718 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1784 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2015 | 944 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2017 | 869 | 0.030 |
Why?
|
G1 Phase | 1 | 2014 | 403 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2012 | 93 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6860 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2012 | 92 | 0.030 |
Why?
|
Pyridones | 1 | 2018 | 809 | 0.030 |
Why?
|
DNA Polymerase II | 1 | 2013 | 104 | 0.030 |
Why?
|
Hemizygote | 1 | 2012 | 28 | 0.030 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2012 | 42 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2013 | 197 | 0.030 |
Why?
|
Base Composition | 1 | 2012 | 290 | 0.030 |
Why?
|
Exosomes | 1 | 2017 | 424 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 12938 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2014 | 883 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 1960 | 0.020 |
Why?
|
Genes, p16 | 1 | 2012 | 160 | 0.020 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2012 | 71 | 0.020 |
Why?
|
E2F Transcription Factors | 1 | 2012 | 269 | 0.020 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2012 | 197 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2017 | 1154 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22163 | 0.020 |
Why?
|
Polyomavirus | 1 | 2012 | 234 | 0.020 |
Why?
|
Enzyme Inhibitors | 2 | 2013 | 3712 | 0.020 |
Why?
|
Vietnam | 1 | 2012 | 409 | 0.020 |
Why?
|
Time Factors | 3 | 2021 | 39975 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 1135 | 0.020 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2013 | 296 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2012 | 460 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 983 | 0.020 |
Why?
|
CpG Islands | 1 | 2015 | 1229 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1699 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2014 | 616 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2015 | 1990 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 934 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2015 | 1093 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2016 | 799 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 471 | 0.020 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 4414 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3514 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 1008 | 0.020 |
Why?
|
SEER Program | 1 | 2015 | 1450 | 0.020 |
Why?
|
Transfection | 2 | 2009 | 5775 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1706 | 0.020 |
Why?
|
Genes, Homeobox | 1 | 2011 | 285 | 0.020 |
Why?
|
Mexico | 1 | 2012 | 763 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 774 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1647 | 0.020 |
Why?
|
Genes, Recessive | 1 | 2012 | 628 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3122 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1890 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1079 | 0.020 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2009 | 46 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3541 | 0.020 |
Why?
|
Nevus | 1 | 2011 | 205 | 0.020 |
Why?
|
Blister | 1 | 2009 | 86 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 164 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2631 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2225 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2393 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1188 | 0.020 |
Why?
|
Luciferases | 1 | 2010 | 714 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 200 | 0.020 |
Why?
|
Platelet Count | 1 | 2011 | 782 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2018 | 2469 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3490 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 855 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 736 | 0.020 |
Why?
|
Adenoviridae | 1 | 2012 | 1084 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3093 | 0.020 |
Why?
|
Blood Coagulation Factors | 1 | 2010 | 365 | 0.020 |
Why?
|
Computer Simulation | 2 | 2012 | 6238 | 0.020 |
Why?
|
Spinal Cord | 1 | 2016 | 1818 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1626 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2012 | 743 | 0.020 |
Why?
|
Sirolimus | 1 | 2014 | 1533 | 0.020 |
Why?
|
Protein Conformation | 1 | 2015 | 3969 | 0.020 |
Why?
|
Melanocytes | 1 | 2011 | 509 | 0.020 |
Why?
|
Ligands | 1 | 2014 | 3271 | 0.020 |
Why?
|
Bile Duct Neoplasms | 1 | 2013 | 605 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2008 | 277 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8469 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 1931 | 0.020 |
Why?
|
Histone Acetyltransferases | 1 | 2009 | 336 | 0.020 |
Why?
|
Point Mutation | 1 | 2012 | 1596 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2449 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1079 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2012 | 732 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1738 | 0.020 |
Why?
|
Cell Separation | 1 | 2012 | 1721 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1870 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6231 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2010 | 1529 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2012 | 1119 | 0.020 |
Why?
|
Incidence | 2 | 2015 | 21341 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 1561 | 0.020 |
Why?
|
DNA Replication | 1 | 2012 | 1418 | 0.020 |
Why?
|
Risk Factors | 3 | 2020 | 74167 | 0.020 |
Why?
|
Pregnancy | 2 | 2007 | 29862 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.020 |
Why?
|
Genes, erbB-2 | 1 | 2005 | 162 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2006 | 256 | 0.020 |
Why?
|
Plasmids | 1 | 2010 | 2269 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2009 | 1791 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2005 | 162 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2820 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2020 | 4467 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6309 | 0.010 |
Why?
|
Colon | 1 | 2012 | 1792 | 0.010 |
Why?
|
Pharmacogenetics | 1 | 2008 | 675 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2009 | 1202 | 0.010 |
Why?
|
Immunotherapy | 1 | 2020 | 4650 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7392 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2072 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2015 | 3466 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1334 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3304 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 17347 | 0.010 |
Why?
|
Proteome | 1 | 2013 | 1862 | 0.010 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2005 | 259 | 0.010 |
Why?
|
Microarray Analysis | 1 | 2005 | 749 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2004 | 1306 | 0.010 |
Why?
|
Chemokines, CXC | 1 | 2004 | 422 | 0.010 |
Why?
|
Chemokine CXCL12 | 1 | 2004 | 454 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4764 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8633 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 2918 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5868 | 0.010 |
Why?
|
Gene Library | 1 | 2004 | 1059 | 0.010 |
Why?
|
Thiazoles | 1 | 2008 | 1517 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6178 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10766 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3092 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2004 | 926 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2005 | 4174 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2008 | 1994 | 0.010 |
Why?
|
Epithelium | 1 | 2004 | 1603 | 0.010 |
Why?
|
Hemorrhage | 1 | 2011 | 3425 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12970 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9612 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2011 | 3576 | 0.010 |
Why?
|
Pediatrics | 1 | 2014 | 3595 | 0.010 |
Why?
|
Carcinoma in Situ | 1 | 2004 | 791 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18400 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10194 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2566 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7956 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 12951 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2009 | 2298 | 0.010 |
Why?
|
Epilepsy | 1 | 2012 | 3290 | 0.010 |
Why?
|
Antigens, CD | 1 | 2007 | 4001 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7856 | 0.010 |
Why?
|
Breast | 1 | 2004 | 1966 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11526 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 9179 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 54415 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15498 | 0.000 |
Why?
|
Brain | 1 | 2014 | 27107 | 0.000 |
Why?
|